Clinical aspects and treatment of pain in children and adolescents with cancer

被引:19
作者
Caran, EMM [1 ]
Dias, CG [1 ]
Seber, A [1 ]
Petrilli, AS [1 ]
机构
[1] Univ Fed Sao Paulo, Inst Oncol Pediat, BR-04023062 Sao Paulo, Brazil
关键词
pain; pediatric oncology; support care;
D O I
10.1002/pbc.20523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The aim of this study was to characterize the clinical aspects and the treatment of mild to severe pain in Brazilian children and adolescents with cancer. We evaluated the importance of classifying patients according to the phase of cancer treatment (diagnosis, treatment, recurrence, and end-of-life palliative care) and the opioid-related side effects. Methods. An institutional prospective study of 184 episodes of pain in children and adolescents with cancer was conducted. Pain was classified according to its cause, physiopathology and intensity. Treatment was based on the WHO guidelines for cancer pain relief. Results. Pain scales were completed by 77% of the patients. Numerical scales were used by 49% of them. Morphine was given in 111 episodes for 2,758 patient days. Morphine doses had to be escalated when it was given to patients during end-of-life palliative care. Opioids were well tolerated with no severe side effects. Psychological dependence on morphine was found in 2% (2/111) of the cases. Pain control was satisfactory in 97% of the episodes. Conclusions. The WHO guidelines for cancer pain relief were effective in controlling pain in children and adolescents with cancer. Despite their low socioeconomic level, patients were able to quantify their pain using rating scales.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 27 条
[1]  
CLARO MT, 1993, THESIS PRETO U SAO P
[2]   CONTINUOUS INTRAVENOUS-INFUSION OF MORPHINE FOR SEVERE DYSPNEA [J].
COHEN, MH ;
ANDERSON, AJ ;
KRASNOW, SH ;
SPAGNOLO, SV ;
CITRON, ML ;
PAYNE, M ;
FOSSIECK, BE .
SOUTHERN MEDICAL JOURNAL, 1991, 84 (02) :229-234
[3]   IS DISEASE PROGRESSION THE MAJOR FACTOR IN MORPHINE-TOLERANCE IN CANCER PAIN TREATMENT [J].
COLLIN, E ;
POULAIN, P ;
GAUVAINPIQUARD, A ;
PETIT, G ;
PICHARDLEANDRI, E .
PAIN, 1993, 55 (03) :319-326
[4]   The measurement of symptoms in young children with cancer: The validation of the Memorial Symptom Assessment Scale in children aged 7-12 [J].
Collins, JJ ;
Devine, TD ;
Dick, GS ;
Johnson, EA ;
Kilham, HA ;
Pinkerton, CR ;
Stevens, MM ;
Thaler, HT ;
Portenoy, RK .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (01) :10-16
[5]   Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain [J].
Dougherty, M ;
DeBaun, MR .
JOURNAL OF PEDIATRICS, 2003, 142 (04) :373-376
[6]   Chronic phantom sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation [J].
Ehde, DM ;
Czerniecki, JM ;
Smith, DG ;
Campbell, KM ;
Edwards, WT ;
Jensen, MP ;
Robinson, LR .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2000, 81 (08) :1039-1044
[7]   Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting [J].
Flogegård, H ;
Ljungman, G .
MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (04) :233-238
[8]   Assessment and treatment of neuropathic cancer pain following WHO guidelines [J].
Grond, S ;
Radbruch, L ;
Meuser, T ;
Sabatowski, R ;
Loick, G ;
Lehmann, KA .
PAIN, 1999, 79 (01) :15-20
[9]   Analysis of the circumstances at the end of life in children with cancer: Symptoms, suffering and acceptance [J].
Hongo, T ;
Watanabe, C ;
Okada, S ;
Inoue, N ;
Yajima, S ;
Fujii, Y ;
Ohzeki, T .
PEDIATRICS INTERNATIONAL, 2003, 45 (01) :60-64
[10]   Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation [J].
Klepstad, P ;
Kaasa, S ;
Skauge, M ;
Borchgrevink, PC .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2000, 44 (06) :656-664